NeutriSci Announces Strategic Distribution Agreement With Wallace & Carey

VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 9, 2016) - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE:NU) the innovator and pioneer behind NeuEnergy™, is pleased to announce that it has entered into a long term distribution agreement with Wallace & Carey Inc. ("Wallace & Carey").

Wallace & Carey operates as a Canadian distribution and logistics company representing brands such as Coke, Hershey's, Dove, Advil, Duracell and Colgate. Wallace & Carey is one of the nation's largest distribution and logistics companies, serving more than 3,500 locations across the country. Wallace & Carey distributes to many of Canada's largest retail chains, theatre chains, and many of the country's most successful independent businesses such as Petro Canada, Chevron, Cineplex and Landmark Cinemas. It offers its services for various product specialties, such as groceries, confectioneries, sundries, health and beauty products, frozen foods, tobacco products, cinema confectioneries, and automotive products.

NeutriSci President, Mr. Glen Rehman stated, "We have been working diligently to expand distribution and ultimately grow sales across Canada. This agreement gives NeutriSci an instant national distribution partner to further complement our existing retail locations providing consumers added choice when purchasing NeuEnergy. Our goal is to have NeuEnergy available in over 4,000 retail locations across Canada by December of 2016."

NeuEnergy™ is a revolutionary energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash associated with typical energy products.

To find out more about NeuEnergy. visit www.getneuenergy.com.

On Behalf of the Board of Directors of

NEUTRISCI INTERNATIONAL INC.

Glen Rehman, President

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward- looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci has focused on the development of several breakthrough nutraceutical products with an initial focus on areas such as heart and cholesterol health, sleep deprivation therapies, immune defense as well as men's prostate and sexual health. NeutriSci continues to build strong relationships and distribution channels for its BluScience™ and NeuEnergy™ products with retailers throughout the United States. NeutriSci is focusing efforts in strengthening sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers. For more information, visit: www.neutrisci.com.

Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.